Isabel Pavão Martins

Prof. Dr. Isabel Pavão Martins


Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2006 in JAMA
Verified
Journal Article
Closed access
PDF file
TDTimothy A. DeRouen
Timothy A. DeRouen
MMMichael D. Martin
Michael D. Martin
BLBrian G. Leroux
Brian G. Leroux
BTBrenda D. Townes
Brenda D. Townes
JWJames S. Woods
James S. Woods
IMIsabel Pavão Martins
Isabel Pavão Martins
Research from JAMA — Neurobehavioral Effects of Dental Amalgam in Children — A Randomized Clinical Trial — ContextDental (silver) amalgam is a widely used restorative material containing 50% elemental mercury that emits small amounts of mercury vapor. No randomized clinical trials have determined whether there are significant health risks associated with this low-level mercury exposure.ObjectiveTo assess the safety of dental amalgam restorations in children.DesignA randomized clinical trial in which children requiring dental restorative treatment were randomized to either amalgam for posterior restorations or resin composite instead of amalgam. Enrollment commenced February 1997, with annual follow-up for 7 years concluding in July 2005.Setting and ParticipantsA total of 507 children in Lisbon, Portugal, aged 8 to 10 years with at least 1 carious lesion on a permanent tooth, no previous exposure to amalgam, urinary mercury level <10 μg/L, blood lead level <15 μg/dL, Comprehensive Test of Nonverbal Intelligence IQ ≥67, and with no interfering health conditions.InterventionRoutine, standard-of-care dental treatment, with one group receiving amalgam restorations for posterior lesions (n = 253) and the other group receiving resin composite restorations instead of amalgam (n = 254).Main Outcome MeasuresNeurobehavioral assessments of memory, attention/concentration, and motor/visuomotor domains, as well as nerve conduction velocities.ResultsDuring the 7-year trial period, children had a mean of 18.7 tooth surfaces (median, 16) restored in the amalgam group and 21.3 (median, 18) restored in the composite group. Baseline mean creatinine-adjusted urinary mercury levels were 1.8 μg/g in the amalgam group and 1.9 μg/g in the composite group, but during follow-up were 1.0 to 1.5 μg/g higher in the amalgam group than in the composite group (P<.001). There were no statistically significant differences in measures of memory, attention, visuomotor function, or nerve conduction velocities (average z scores were very similar, near zero) for the amalgam and composite groups over all 7 years of follow-up, with no statistically significant differences observed at any time point (P values from .29 to .91). Starting at 5 years after initial treatment, the need for additional restorative treatment was approximately 50% higher in the composite group.ConclusionsIn this study, children who received dental restorative treatment with amalgam did not, on average, have statistically significant differences in neurobehavioral assessments or in nerve conduction velocity when compared with children who received resin composite materials without amalgam. These findings, combined with the trend of higher treatment need later among those receiving composite, suggest that amalgam should remain a viable dental restorative option for children.Trial Registrationclinicaltrials.gov Identifier: NCT00066118

1 March 2022 in Stroke
Verified
Journal Article
Open access
PDF file
TCThe REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) Collaborators
The REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) Collaborators
MBMarian C. Brady
Marian C. Brady
MAMyzoon Ali
Myzoon Ali
KVKathryn VandenBerg
Kathryn VandenBerg
LWLinda J. Williams
Linda J. Williams
HWHeather Harris Wright
Heather Harris Wright
Background and Purpose: Optimizing speech and language therapy (SLT) regimens for maximal aphasia recovery is a clinical research priority. We examined associations between SLT intensity (hours/week), dosage (total hours), frequency (days/week), duration (weeks), delivery (face to face, computer supported, individual tailoring, and home practice), content, and language outcomes for people with aphasia. Methods: Databases including MEDLINE and Embase were searched (inception to September 2015). Published, unpublished, and emerging trials including SLT and ≥10 individual participant data on aphasia, language outcomes, and time post-onset were selected. Patient-level data on stroke, language, SLT, and trial risk of bias were independently extracted. Outcome measurement scores were standardized. A statistical inferencing, one-stage, random effects, network meta-analysis approach filtered individual participant data into an optimal model examining SLT regimen for overall language, auditory comprehension, naming, and functional communication pre-post intervention gains, adjusting for a priori–defined covariates (age, sex, time poststroke, and baseline aphasia severity), reporting estimates of mean change scores (95% CI). Results: Data from 959 individual participant data (25 trials) were included. Greatest gains in overall language and comprehension were associated with >20 to 50 hours SLT dosage (18.37 [10.58–26.16] Western Aphasia Battery–Aphasia Quotient; 5.23 [1.51–8.95] Aachen Aphasia Test–Token Test). Greatest clinical overall language, functional communication, and comprehension gains were associated with 2 to 4 and 9+ SLT hours/week. Greatest clinical gains were associated with frequent SLT for overall language, functional communication (3–5+ days/week), and comprehension (4–5 days/week). Evidence of comprehension gains was absent for SLT ≤20 hours, <3 hours/week, and ≤3 days/week. Mixed receptive-expressive therapy, functionally tailored, with prescribed home practice was associated with the greatest overall gains. Relative variance was <30%. Risk of trial bias was low to moderate; low for meta-biases. Conclusions: Greatest language recovery was associated with frequent, functionally tailored, receptive-expressive SLT, with prescribed home practice at a greater intensity and duration than reports of usual clinical services internationally. These exploratory findings suggest critical therapeutic ranges, informing hypothesis-testing trials and tailoring of clinical services. Registration: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD42018110947.

16 October 2014 in Cephalalgia
Verified
Journal Article
Closed access
RGRaquel Gil-Gouveia
Raquel Gil-Gouveia
AOAntónio G Oliveira
António G Oliveira
IMIsabel Pavão Martins
Isabel Pavão Martins
Cognitive difficulties contribute to patients’ disability during migraine attacks and have been overlooked in migraine research. Neuropsychological studies performed during attacks have produced inconsistent findings due to design differences and limitations. Our objective is to document changes in cognitive performance of migraine patients during migraine attacks with a comprehensive battery of cognitive/behavioral tests, while controlling for potential confounders. A prospective two-period, randomized, cross-over study compared within-subject neuropsychological evaluation in two conditions—during a naturally occurring untreated migraine attack and a headache-free period. Thirty-nine patients with episodic migraine (37 females, average 38 years old) were included and 24 completed the study. Participants performed worse during the attack in the majority of cognitive tests, compared to the headache-free status, and significantly so in word reading speed (p = 0.013), verbal learning (p = 0.01), short-term verbal recall with (p = 0.01) and without (p = 0.013) semantic cueing and delayed recall with (p = 0.003) and without (p = 0.05) semantic cues. Differences found were unrelated to age, gender, literacy, condition order, interval between evaluations, anxiety, pain intensity or duration of the attack. Cognitive performance decreases during migraine attacks, especially in reading and processing speed, verbal memory and learning, supporting patients’ subjective complaints. These findings suggest the existence of a reversible brain dysfunction during attacks of migraine without aura, which can relate specifically to migraine or be a consequence of acute pain processing by the brain.

1 May 2004 in Journal of the International Neuropsychological Society
Verified
Journal Article
Closed access
PDF file
MCMiguel Coelho
Miguel Coelho
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
BDBeatriz Dias
Beatriz Dias
CSCristina Sampaio
Cristina Sampaio
IMIsabel Pavão Martins
Isabel Pavão Martins
ACAlexandre Castro-Caldas
Alexandre Castro-Caldas
Studies concerning time perception lack a validated assessment tool and a consensual “gold-standard” measure. Moreover, the present evidence suggests modification of timing with aging. This study aimed to develop and validate a neuropsychological tool to measure time perception and to study temporal perception with aging. Eighty-six healthy participants, aged 15–90 years old, were asked to verbally estimate and produce empty intervals signaled by auditory beeps, of 7-, 32-, and 58-s duration. Two tests were used as “gold-standards”: estimation of the duration of time necessary to draw a clock (“clock time”) and estimation of the duration of neuropsychological evaluation (“global time”). Results showed a correlation between estimation and production (p < .01) and a correlation between estimation or production and “global time” (p < .01). The correlation between either estimation or production and age (p < .01), suggested a faster “internal-clock” in the older participants. However, this finding lost significance when controlled for literacy. The results suggest that these tests are potentially a useful tool to measure subjective perception of time. They also corroborate the hypothesis of a change in subjective time perception with aging. It was not possible to conclude if this effect was a specific result of aging or biased by the interference of literacy. (JINS, 2004, 10, 332–341.)

1 March 1984 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
JFJosé M. Ferro
José M. Ferro
IMIsabel Pavão Martins
Isabel Pavão Martins
LTLuis Távora
Luis Távora

1 June 2006 in The Journal of Pain
Verified
Journal Article
Closed access
IMIsabel Pavão Martins
Isabel Pavão Martins
RGRaquel Gil-Gouveia
Raquel Gil-Gouveia
EPElsa Parreira
Elsa Parreira